Journal of obstetrics and women's diseasesJournal of obstetrics and women's diseases1684-04611683-9366Eco-Vector265310.17816/JOWD622179-185Research ArticleFeatures of Asthma Treatment while PregnancyLavrovaOlga Voldemarovnaleading researcher of the Laboratory of genetic processes of lung diseasesloverova@bk.ruShapovalovaYelena Andreyevnasenior researcher at the Department of Pathology of pregnancye.shapovalova@mail.ruPetrovaMariya Anatolyevnahead of the Laboratory of genetic processes of lung diseasesmap1946@rambler.ruDymarskayaYuliya Romanovnapostgraduate of department of Obstetrics and Gynecologyjulia_dym@mail.ruSablinaAnna Vladimirovnaobstetrician-gynecologistanna_s-piter@mail.ruResearch Institute of PulmonologyD. O. Ott Research Institute of Obstetrics and Gynecology, RAMSSaint-Petersburg State I. P. Pavlov Medical UniversitySt. Petersburg Women's clinic N 81505201362217918515052013Copyright © 2013, Lavrova O.V., Shapovalova Y.A., Petrova M.A., Dymarskaya Y.R., Sablina A.V.2013The goal of the study was the comparison pregnancy duration, delivery and height-weight ratio of newborns in females with different severity of Asthma duration and various basic therapies. Materials methods. Study group was compounded with 1010 Asthmatic females aged 17–43 years, followed up by our staff together with gynecologists since early terms of their pregnancy. All patients were performed physical exam and functional study. As a result individual prophylaxis and treatment plan was generated for every pregnant. Results: Pulmicort-turbuhaler and SABA administration was significantly less effective in patients with moderate and severe asthma duration in comparison with fluent persistent asthma pregnants. The lowest frequency of gestoses (twice lower in comparison with Pulmicort-turbuhaler treated patients) was fixed in patients, treated with Seretide. Preterm delivery jeopardize was twice higher in Pulmicort-turbuhaler treated group. Frequency of Caesarian section was significantly higher in Pulmicort-turbuhaler treated females in comparison with females, treated with Simbicort. Average height-weight ratio in case of severe Asthma duration was lowest in patients with severe Asthma, who were administered Pulmicort-turbuhaler. Аverage weight value of kids, born by Seretide administered females, was above median value of BA females in total.asthmapregnancytreatmentбронхиальная астмабеременностьтерапия[Глобальная стратегия лечения и профилактики бронхиальной астмы: пер. с англ. / докл. рабочей группы Global Initiative for Asthma. — М.: Атмосфера, 2007.][Купаев В. И., Косарев В. В., Филиппова Т. Ю. Особенности контроля бронхиальной астмы у женщин в период беременности. — Самара: Литфонд, 2004. — 103 с.][Распопина Н. А., Шугинин И. О. Бронхиальная астма и беременность: нерешенные вопросы // Клиническая медицина. — 2003. — № 11. — С. 45–48.][A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring / Tamasi L., Somoskövi A., Müller V. [et al.] // J. Asthma. — 2006. — Vol. 43, N 1. — P. 81–86.][A population-based prescription study of asthma drugs during pregnancy: changing the intensity of asthma therapy and perinatal outcomes / Olesen C., Thrane N., Nielsen G. L. [et al.] // Respiration. — 2001. — Vol. 68, N 3. — P. 256–261.][Alexander S., Dodds L., Armson B. A. Perinatal outcomes in women with asthma during pregnancy // Obstet. Gynecol. — 1998. — Vol. 92, N 3. — P. 435–440.][Asthma during pregnancy: mechanisms and treatment implications / Murphy V. E., Gibson P. G., Smith R., Clifton V. L. // Eur. Respir. J. — 2005. — Vol. 25, N 4. — P. 731–750.][Asthma medication use in pregnancy and fetal growth/Bakhireva L. N., Jones K. L., Schatz M. [et al.] // J. Allergy Clin. Immunol. — 2005. — Vol. 116, N 3. — P. 503–509.][Blais L., Forget A. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women // J. Allergy Clin. Immunol. — 2008. — Vol. 121, N 6. — P. 1379–1384.][Demissie K., Breckenridge M. B., Rhoads G. G. Infant and maternal outcomes in the pregnancies of asthmatic women // Am. J. Respir. Crit. Care Med. — 1998. — Vol. 158, N 4. — P. 1091–1095.][Dombrowski M. P. Outcomes of pregnancy in asthmatic women // Immunol. Allergy Clin. North Am. — 2006. — Vol. 26, N 1. — P. 81–92.][Effect of maternal asthma on birthweight and neonatal outcome in a British inner-city population / Clark J. M., Hulme E., Devendrakumar V. [et al.] // Paediatr. Perinat. Epidemiol. — 2007. — Vol. 21, N 2. — P. 154–162.][Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study / Tata L. J., Lewis S. A., McKeever T. M. [et al.] // Thorax. — 2008. — Vol. 63, № 11. — P. 981–987.][Källén B., Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect // Reprod. Toxicol. — 2003. — Vol. 17, N 3. — P. 255–261.][Källén B., Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. Congenital malformations in the infants // Eur. J. Clin. Pharmacol. — 2007. — Vol. 63, N 4. — P. 383–388.][Lao T. T., Huengsburg M. Labour and delivery in mothers with asthma // Eur. J. Obstet. Gynecol. Reprod. Biol. — 1990. — Vol. 35, N 2–3. — P. 183–190.][Luskin A. T. An overview of the recommendations of the Working Group on Asthma and Pregnancy. National Asthma Education and Prevention Program // Allergy Clin. Immunol. — 1999. — Vol. 103, N 2, pt. 2. — P. S350–S353.][Maternal asthma medication use and the risk of gastroschisis/Lin S., Munsie J. P., Herdt-Losavio M. L. [et al.] // Am. J. Epidemiol. — 2008. — Vol. 168, N 1. — P. 73–79.][Maternal asthma, asthma medication use, and the risk of congenital heart defects / Lin S., Herdt-Losavio M., Gensburg L. [et al.] // Birth Defects Res. Clin. Mol. Teratol. — 2009. — Vol. 85, N 2. — P. 161–168.][NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update // J. Allergy Clin. Immunol. — 2005. — Vol. 115, N 1. — P. 34–46.][Salmeterol use and pregnancy outcome: a prospective multi-center study / Jones K. L., Johnson D. L., Van Maarseveen N. D. [et al.] // J. Allergy Clin. Immunol. — 2002. — Vol. 109, suppl. — P. S156.][Schatz M., Zeiger R. S. Improving asthma outcomes in large populations // J. Allergy Clin. Immunol. — 2011. — Vol. 128, N 2. — P. 273–277.][Schatz M., Zeiger R. S., Hoffman C. P. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women // Chest. — 1990. — Vol. 98, N 2. — P. 389–392.][Tan K. S., Thomson N. C. Asthma in pregnancy // Am. J. Med. — 2000. — Vol. 109, N 9. — P. 727–733.][The relationship of asthma medication use to perinatal outcomes / Schatz M., Dombrowski M. P., Wise R. [et al.] // J. Allergy Clin. Immunol. — 2004. — Vol. 113, N 6. — P. 1040–1045.][The safety of asthma and allergy medications during pregnancy / Schatz M., Zeiger R. S., Harden K. [et al.] // J. Allergy Clin. Immunol. — 1997. — Vol. 100, N 3. — P. 301–306.][The safety of inhaled beta-agonist bronchodilators during pregnancy / Schatz M., Zeiger R. S., Harden K. M. [et al.] // J. Allergy Clin. Immunol. — 1988. — Vol. 82, N 4. — P. 686–695.]